Laurence Huang, MD
|Title||Professor of Clinical |
|School||UCSF School of Medicine|
|Address||1001 Potrero Ave, SFGH 80|
|University of California San Francisco Positive Health Program, HIV/AIDS Division||2009||Positive Health Program Award for Teaching Excellence-Meg Newman Teaching Award|
|University of California San Francisco AIDS Research Institute||2005||George S. Sarlo Award for Excellence in Teaching and Mentoring|
|University of California San Francisco ||2005||Haile T. Debas Academy of Medical Educators Excellence in Direct Teaching Award|
|Centers for Disease Control and Prevention||2001||James H. Nakano Citation (for Outstanding Scientific Paper published in 2000)|
|American College of Physicians-American Society of Internal Medicine||2000||Community Based Teaching Excellence and Preceptorship Award|
|American Lung Association ||1995||Walter Travel Fund Award|
|Johns Hopkins University||1984||Omicron Delta Kappa-National Leadership Honor Society|
I am a pulmonary and critical care medicine specialist with a research focus on pulmonary diseases affecting persons with HIV. Currently, I am PI/Co-PI on 2 main studies:
IHOP: The International HIV-associated Opportunistic Pneumonias (IHOP) Study is a multi-national cohort study whose goal is to improve our understanding of the epidemiology, etiology, and outcome of pneumonias in persons with HIV infection. IHOP is part of the Lung HIV Study, a collaborative multi-R01 consortium established by the National Heart, Lung, and Blood Institute (NHLBI) to examine a diverse range of infectious and non-infectious pulmonary diseases in HIV-infected persons.
Lung MicroChip: The Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroChip) Study is a multi-cohort study whose goal is to examine the composition and function of the lung microbiome in persons with HIV. Lung MicroChip is part of the Lung HIV Microbiome Project, a collaborative multi-U01 consortium established by the NHLBI to study the lung microbiome in HIV infection.
1. Determine the etiology and mortality of HIV-associated opportunistic pneumonias in an international, multi-center, longitudinal cohort
2. Study PCP epidemiology, diagnosis, drug-resistance, and host immune response
3. Develop and validate new molecular applications to study PCP, TB, and other HIV-associated opportunistic pneumonias
4. Study the composition and function of the lung microbiome in persons with HIV infection
5. Examine whether PCP results from person-to-person transmission (as has been convincingly demonstrated from animal-to-animal laboratory studies) and whether disease results from reactivation of latent infection or from recent exposure and infection
Click the "See All" links for more information and interactive visualizations!
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share similar concepts with this person.